Junction-targeting designs limit the application of CRISPR-Cas13d in circular RNA perturbation studies

Yannick C Lee-Yow1,2, Raeline C Valbuena1, Chiara S Richter1,2

  • 1Department of Genetics, Stanford University School of Medicine, Stanford, CA 94304, United States.

Nucleic Acids Research
|January 8, 2026
PubMed

Insights

CRISPR-Cas13 systems targeting circular RNAs (circRNAs) show limitations, with many single-guide RNAs causing off-target effects on linear RNAs. Most tested circRNAs did not impact cell proliferation in essentiality screens.

Area of Science:

  • Molecular Biology
  • Genomics
  • RNA Biology

Background:

  • Circular RNAs (circRNAs) are formed by backsplicing, with thousands identified but few functionally characterized.
  • Distinguishing circRNA effects from linear RNA targets poses a significant challenge in functional studies.
  • CRISPR-Cas13 systems offer potential for selective targeting of unique circRNA junctions.

Purpose of the Study:

  • To assess the limitations of Cas13d-mediated knockdown for studying circular RNAs.
  • To evaluate the efficacy and specificity of single-guide RNAs (sgRNAs) targeting circRNA junctions.
  • To determine the functional impact of highly expressed circRNAs on cell proliferation.

Main Methods:

  • Performed essentiality screens using CRISPR-Cas13d targeting 900 circRNAs in K562 cells.
  • Analyzed off-target knockdown effects on linear RNA isoforms.
  • Re-analyzed existing Cas13d screens in other cell types.
  • Developed machine learning models to predict Cas13d sgRNA efficacy.
  • Assessed circRNA effects on cell proliferation.

Main Results:

  • Observed consistent off-target knockdown of linear isoforms by circRNA-targeting sgRNAs.
  • Identified similar off-target effects in previously published Cas13d screens.
  • Machine learning models predicted low knockdown efficacy for most circRNA-targeting sgRNAs.
  • Found 0 out of 346 testable circRNAs had detectable effects on proliferation after accounting for design constraints.

Conclusions:

  • CRISPR-Cas13d junction-targeting strategies have significant limitations, including off-target effects and low sgRNA efficacy.
  • Current junction-targeting approaches may overestimate the functional importance of circRNAs.
  • These findings necessitate careful consideration of design constraints for future circRNA perturbation studies.

Related Concept Videos

CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.7K
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.4K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.6K